A detailed history of Bellevue Group Ag transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 16,900 shares of ADMA stock, worth $280,709. This represents 0.01% of its overall portfolio holdings.

Number of Shares
16,900
Previous 25,900 34.75%
Holding current value
$280,709
Previous $517,000 44.1%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$15.62 - $22.62 $140,580 - $203,580
-9,000 Reduced 34.75%
16,900 $289,000
Q3 2024

Nov 14, 2024

SELL
$11.21 - $20.03 $56,050 - $100,150
-5,000 Reduced 16.18%
25,900 $517,000
Q2 2024

Aug 14, 2024

SELL
$5.98 - $11.18 $59,800 - $111,800
-10,000 Reduced 24.45%
30,900 $345,000
Q1 2024

May 15, 2024

BUY
$4.4 - $6.74 $179,960 - $275,666
40,900 New
40,900 $269,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.26B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.